255 related articles for article (PubMed ID: 8561868)
1. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
Stang S; Bottorff D; Stone JC
Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Ras effector mutant interactions with the NF1-GAP related domain.
Marshall MS; Hettich LA
Oncogene; 1993 Feb; 8(2):425-31. PubMed ID: 8426748
[TBL] [Abstract][Full Text] [Related]
3. Differences in the interaction of p21c-Ha-ras-GMP-PNP with full-length neurofibromin and GTPase-activating protein.
DiBattiste D; Golubic M; Stacey D; Wolfman A
Oncogene; 1993 Mar; 8(3):637-43. PubMed ID: 8437847
[TBL] [Abstract][Full Text] [Related]
4. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
[TBL] [Abstract][Full Text] [Related]
5. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.
Basu TN; Gutmann DH; Fletcher JA; Glover TW; Collins FS; Downward J
Nature; 1992 Apr; 356(6371):713-5. PubMed ID: 1570015
[TBL] [Abstract][Full Text] [Related]
6. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
Hattori S; Maekawa M; Nakamura S
Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
[TBL] [Abstract][Full Text] [Related]
7. Control of ras activation.
Downward J
Cancer Surv; 1996; 27():87-100. PubMed ID: 8909796
[TBL] [Abstract][Full Text] [Related]
8. A conserved region of c-Ha-Ras is required for efficient GTPase stimulation by GTPase activating protein but not neurofibromin.
Yoder-Hill J; Golubic M; Stacey DW
J Biol Chem; 1995 Nov; 270(46):27615-21. PubMed ID: 7499225
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.
Hiatt KK; Ingram DA; Zhang Y; Bollag G; Clapp DW
J Biol Chem; 2001 Mar; 276(10):7240-5. PubMed ID: 11080503
[TBL] [Abstract][Full Text] [Related]
10. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
[TBL] [Abstract][Full Text] [Related]
11. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.
Bollag G; Clapp DW; Shih S; Adler F; Zhang YY; Thompson P; Lange BJ; Freedman MH; McCormick F; Jacks T; Shannon K
Nat Genet; 1996 Feb; 12(2):144-8. PubMed ID: 8563751
[TBL] [Abstract][Full Text] [Related]
12. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.
Warne PH; Viciana PR; Downward J
Nature; 1993 Jul; 364(6435):352-5. PubMed ID: 8332195
[TBL] [Abstract][Full Text] [Related]
13. Direct measurement of the binding of RAS to neurofibromin using a scintillation proximity assay.
Skinner RH; Picardo M; Gane NM; Cook ND; Morgan L; Rowedder J; Lowe PN
Anal Biochem; 1994 Dec; 223(2):259-65. PubMed ID: 7887472
[TBL] [Abstract][Full Text] [Related]
14. Coupling of ras p21 signalling and GTP hydrolysis by GTPase activating proteins.
McCormick F
Philos Trans R Soc Lond B Biol Sci; 1992 Apr; 336(1276):43-7; discussion 47-8. PubMed ID: 1351295
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of rasGAP and neurofibromatosis gene product activities.
Bollag G; McCormick F
Nature; 1991 Jun; 351(6327):576-9. PubMed ID: 1904555
[TBL] [Abstract][Full Text] [Related]
16. Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction.
Stone JC; Colleton M; Bottorff D
Mol Cell Biol; 1993 Dec; 13(12):7311-20. PubMed ID: 8246952
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis.
Gutmann DH; Boguski M; Marchuk D; Wigler M; Collins FS; Ballester R
Oncogene; 1993 Mar; 8(3):761-9. PubMed ID: 8437860
[TBL] [Abstract][Full Text] [Related]
18. The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cells.
Barlat I; Schweighoffer F; Chevallier-Multon MC; Duchesne M; Fath I; Landais D; Jacquet M; Tocque B
Oncogene; 1993 Jan; 8(1):215-8. PubMed ID: 7999142
[TBL] [Abstract][Full Text] [Related]
19. R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation.
Rey I; Taylor-Harris P; van Erp H; Hall A
Oncogene; 1994 Mar; 9(3):685-92. PubMed ID: 8108110
[TBL] [Abstract][Full Text] [Related]
20. Alternate mechanisms of ras activation are complementary and favor and formation of ras-GTP.
Patel G; MacDonald MJ; Khosravi-Far R; Hisaka MM; Der CJ
Oncogene; 1992 Feb; 7(2):283-8. PubMed ID: 1549350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
